Post by UST

Our team joined Agios Pharmaceuticals at SAP Connect Days for Life Sciences to share what it takes to modernize a regulated life sciences supply chain. For Agios, moving to SAP meant building a GxP-validated operating foundation for an expanding business with multi-market complexity, outsourced manufacturing, and growing clinical and commercial demand. We partnered with Agios to understand the complexity behind the business, then helped turn a fragmented, spreadsheet-driven supply chain into a validated SAP foundation across planning, inventory, genealogy, costing, quality, and finance. The result is a validated supply chain foundation with batch genealogy and cost accounting that supports Agios in with care impact: • Patient outcomes: GxP-compliant batch genealogy and lot disposition support safe, quality-controlled supply of rare disease therapies across markets. • Time to patient access: IBP-driven planning connected to S/4HANA improves response to CMO production and demand shifts. • Cost of care: Actual batch costing, automated Oracle integration, and fewer manual accruals reduce operational cost and financial risk. • Experience of care: A unified inventory and planning platform supports consistent, traceable supply across US, EU, and global markets. That’s where SAP transformation creates change that people can feel every day. #LifeSciences #SAP #HealthIT